- Quest Diagnostics set its annual shareholder meeting for May 20, 2026 in Clifton, New Jersey.
- Shareholders will vote to elect 11 directors.
- Meeting agenda includes an advisory vote on executive compensation.
- Shareholders will also vote on ratification of PricewaterhouseCoopers as independent auditor for fiscal 2026.
- Items include shareholder proposal seeking policy requiring an independent board chairman.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quest Diagnostics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-013356), on April 06, 2026, and is solely responsible for the information contained therein.
Comments